Taysha Gene Market Risk Adjusted Performance
| TSHA Stock | | | USD 4.45 -0.12 -2.63% |
Reference data associated with the Market Risk Adjusted Performance technical indicator for Taysha Gene Therapies. Indicator inputs depend on available historical price observations.
Taysha Gene Therapies has current Market Risk Adjusted Performance of
-0.39.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.39 | |
| ER[a] | = | Expected return on investing in Taysha Gene |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Taysha Gene Therapies is rated
below average in market risk adjusted performance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
Other Technical Indicators